Jula Inrig insider trades
Open-market stock purchases and sales by Jula Inrig, EVP, Head of R&D & CMO at Travere Therapeutics, Inc, from SEC Form 4 filings since Jan 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.6M |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.1M |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $102K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $26.1K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Jun 22, 2026 | TVTX Travere Therapeutics, Inc | Sold (not open market) | — |
| May 6, 2026 | TVTX Travere Therapeutics, Inc | Sold | $13.7K |
| May 5, 2026 | TVTX Travere Therapeutics, Inc | Sold | $101K |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $900K |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $43.4K |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $303K |
| Apr 13, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Feb 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $7.6K |
| Feb 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $49.7K |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc | Sold | $223K |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Jan 6, 2026 | TVTX Travere Therapeutics, Inc | Sold | $16.8K |
| Jan 5, 2026 | TVTX Travere Therapeutics, Inc | Sold | $81.6K |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc | Sold | $630K |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TVTX Travere Therapeutics, Inc: 28 sales, last Sep 15, 2026